Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 216

The DOI matches its Crossref record.

Campath-1H–Induced Complete Remission of Chronic Lymphocytic Leukemia despite p53 Gene Mutation and Resistance to Chemotherapy

Open access
Stilgenbauer, Stephan, Döhner, Hartmut·2002·New England Journal of Medicine

Abstract

To the Editor: Treatment of chronic lymphocytic leukemia (CLL) with fludarabine results in a higher remission rate and longer progression-free survival than do alkylating agents.1 Patients who have no response to fludarabine have a dismal prognosis, with a median survival of 10 months.2 In these patients the anti–CD52 antibody alemtuzumab (Campath-1H, MabCampath) has recently shown promising results, with an overall response rate of 33 percent.3 The molecular mechanisms of its action and the biologic factors associated with the clinical response are not well defined. A 72-year-old woman was given a diagnosis of CLL, Binet stage A, in August 1997. Because . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm200208083470619

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 216

Metadata

Authors
Stilgenbauer, S., & Döhner, H.
Venue
New England Journal of Medicine
Published
2002-08-08
Volume
347
Issue
6
Pages
452-453
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2026805676
Cited by
216
References
0
FWCI
5.43
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Campath-1H–Induced Complete Remission of Chronic Lymphocytic Leukemia despite p53 Gene Mutation and Resistance to Chemotherapy. https://app.cochat.ai/papers/10.1056/nejm200208083470619
The paper
Stilgenbauer, S., & Döhner, H. (2002). Campath-1H–Induced Complete Remission of Chronic Lymphocytic Leukemia despite p53 Gene Mutation and Resistance to Chemotherapy. New England Journal of Medicine. https://doi.org/10.1056/nejm200208083470619

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.